Factors underlying chronic inflammation in rheumatoid arthritis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 52, Issue 6, 2004, Pages 379-388

  See, Heng Wong ^a   Lord, Janet M ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Apoptosis; Chemokines; Cytokines; Fibroblasts; Inflammation

Indexed keywords

ADALIMUMAB; COLLAGENASE; CYTOKINE; ETANERCEPT; IMATINIB; INFLIXIMAB; INTERFERON; TUMOR NECROSIS FACTOR;

APOPTOSIS; B LYMPHOCYTE; CELL FUNCTION; CELL INFILTRATION; CHRONIC INFLAMMATION; CLINICAL TRIAL; CYTOKINE PRODUCTION; FIBROBLAST; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HEREDITY; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROENVIRONMENT; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REVIEW; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; SYNOVIUM; T LYMPHOCYTE;

ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; CHRONIC DISEASE; CYTOKINES; HUMANS; INFLAMMATION; MACROPHAGES; NEUTROPHILS; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 12244301631     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (98)

1. Adebajo A. O. (1995): Tropical rheumatology. Epidemiology and community studies: Africa. Baillieres Clin. Rheumatol., 9, 21-30.
2. Adebajo A. O. and Hazleman B. L.(1996): Malaria and rheumatoid arthritis in West Africa. Clin. Exp. Rheumatol., 14, 346.
3. Arend W. P., Malyak M., Guthridge C. J. and Gabay C. (1998): Interleukin-1 receptor antagonist: role in biology. Annu. Rev. Immunol., 16, 27-55.
4. Aupperle K. R., Bennett B. L., Boyle D. L., Tak P. P., Manning A. M. and Firestein G. S. (1999): NF-κB regulation by IκB kinase in primary fibroblast-like synoviocytes. J. Immunol., 163, 427-433.
5. Badger A. M., Griswold D. E., Kapadia R., Blake S., Swift B. A., Hoffman S. J., Stroup G. B., Webb E., Rieman D. J., Gowen M., Boehm J. C., Adams J. L. and Lee J. C. (2000): Disease-modifying activity of SB 242235, a selective inhibitor of p38 mitogen-activated protein kinase, in rat adjuvant-induced arthritis. Arthritis Rheum., 43, 175-183.
6. Barber G. N. (2000): The interferons and cell death: guardians of the cell or accomplices of apoptosis? Semin. Cancer Biol., 10, 103-111.
7. Borregaard N. and Cowland J. B. (1997): Granules of the human neutrophilic polymorphonuclear leukocyte. Blood, 89, 3503-3521.
8. Brennan F. M., Hayes A. L., Ciesielski C. J., Green P., Foxwell B. M. J. and Feldmann M. (2001): Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinasc and nuclear factor κB pathways in tumor necrosis factor a production in rheumatoid arthritis. Arthitis Rheum., 46, 31-41.
9. Bresnihan B., Alvaro-Gracia J. M., Cobby M., Doherty M., Domljan Z., Emery P., Nuki G., Pavelka K., Rau R., Rozman B., Watt I., Williams B., Aitchison R., McCabe D. and Musikic P. (1998): Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis Rheum., 41, 2196-2204.
10. Bucala R., Ritchlin C., Winchester R. and Cerami A. (1991): Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J. Exp. Med., 173, 569-574.
11. Buckley C. D., Amft N., Bradfield P. F., Pilling D., Ross E., Arenzana-Seisdedos F., Amara, A., Curnow, S. J., Lord, J. M., Scheel-Toellner D. and Salmon M. (2000): Persistent induction of the chemokine receptor CXCR4 by TGF-β 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J. Immunol., 165, 3423-3429.
12. Buckley C. D., Pilling D., Lord J. M., Akbar A. N., Scheel-Toellner D. and Salmon M. (2001): Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol., 22, 199-204.
13. Cassatella M. A. (1995): The production of cytokines by polymorphonuclear neutrophils. Immunol. Today, 16, 21-26.
14. Ceponis A., Konttinen Y. T., Imai S., Tamulaitiene M., Li T. F., Xu J. W., Hietanen J., Santavirta S. and Fassbender H. G. (1998): Synovial lining, endothelial and inflammatory mononuclear cell proliferation in synovial membranes in psoriatic and reactive arthritis: a comparative quantitative morphometric study. Br. J. Rheumatol., 37, 170-178.
15. Clohisy J. C., Roy B. C., Biondo C., Frazier E., Willis D., Teitelbaum S. L. and Abu-Amer Y. (2003): Direct inhibition of NF-κB blocks bone erosion associated with inflammatory arthritis. J. Immunol., 171, 5547-5553.
16. Cohen S., Hurd E., Cush J., Schiff M., Weinblatt M. E., Moreland L. W., Kremer J., Bear M. B., Rich W. J. and McCabe D. (2002): Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum., 46, 614-624.
17. Colotta F., Re F., Polentarutti N., Sozzani S. and Mantovani A. (1992): Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood, 80, 2012-2020.
18. Cordero O. J., Salgado F. J., Mera-Varela A. and Nogueira M. (2001): Serum interleukin-12, interleukin-15, soluble CD26, and adenosine deaminase in patients with rheumatoid arthritis. Rheumatol. Int., 21. 69-74.
19. Crawford S. M. (1984): Neutrophils and adult respiratory distress syndrome. Lancet, 2, 1392-1393.
20. Croft D. R., Dall P., Davies D., Jackson D. G., McIntyre P. and Kramer I. M. (1997): Complex CD44 splicing combinations in synovial fibroblasts from arthritic joints. Eur. J. Immunol., 27, 1680-684.
21. Cross A., Bucknall R. C., Cassatella M. A., Edwards S. W. and Moots R. J. (2003): Synovial fluid neutrophils transcribe and express class II major histocompatibility complex molecules in rheumatoid arthritis. Arthritis Rheum., 48, 2796-2806.
22. Dai S. M., Matsuno H., Nakamura H., Nishioka K. and Yudoh K. (2004): Interleukin-18 enhances monocyte tumor necrosis factor α and interleukin-1β production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis. Arthritis Rheum., 50, 432-443.
23. Edwards S. W. (1994): Biochemistry and physiology of the neutrophil. Cambridge University Press.
24. Edwards S. W. and Hallett M. B. (1997): Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol. Today, 18, 320-324.
25. Elliott M. J., Maini R. N., Feldmann M., Kalden J. R., Antoni C., Smolen J. S., Leeb B., Breedveld F. C., Macfarlane J. D., Bijl H. and Woody J. N. (1994): Randomised double-blind comparison of chimcric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet, 344, 1105-1110.
26. Feldmann M., Andreakos E., Smith C., Bondeson J., Yoshimura S., Kiriakidis S., Monaco C., Gasparini C., Sacre S., Lundberg A., Paleolog E., Horwood N. J., Brennan F. M. and Foxwell B. M. (2002): Is NF-κB a useful therapeutic target in rheumatoid arthritis? Ann. Rheum. Dis., 61 (suppl. 2), ii13-ii18.
27. Feldmann M., Brennan F. M. and Maini R. N. (1996): Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol., 14, 397-440.
28. Feng Y., Schreiner G. F., Chakravarty S., Liu D. Y. and Joly A. H. (2001): Inhibition of the mitogen activated protein kinase, p38 α, prevents proinflammatory cytokine induction by human adherent mononuclear leukocytes in response to lipid loading. Atherosclerosis, 158, 331-338.
29. Firestein G. S. and Zvaifler N. J. (1990): How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum., 33, 768-773.
30. Fleming Y., Armstrong C. G., Morrice N., Paterson A., Goedert M. and Cohen P. (2000): Synergistic activation of stress-activated protein kinase 1/c-Jun N-terminal kinase (SAPK1/JNK) isoforms by mitogen-activated protein kinase kinase 4 (MKK4) and MKK7. Biochem. J., 352, 145-154.
31. Fujisawa K., Aono H., Hasunuma T., Yamamoto K., Mita S. and Nishioka K. (1996): Activation of transcription factor NF-κB in human synovial cells in response to tumor necrosis factor α. Arthritis Rheum., 39, 197-203.
32. Geiler T., Kriegsmann J., Keyszer G. M., Gay R. E. and Gay S. (1994): A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthritis Rheum., 37: 1664-1671.
33. Grootveld M., Henderson E. B., Farrell A., Blake D. R., Parkes H. G. and Haycock P. (1991): Oxidative damage to hyaluronate and glucose in synovial fluid during exercise of the inflamed rheumatoid joint. Detection of abnormal low-molecular-mass metabolites by proton-n.m.r. spectroscopy. Biochem. J., 273, 459-467.
34. Gulko P. S., Seki T. and Winchester R. (2000): Rheumatoid arthritis. Frontiers in pathogenesis and treatment, 113-135.
35. Handel M. L., McMorrow L. B. and Gravallese E. M. (1995): Nuclear factor-κB in rheumatoid svnovium. Localization of p50 and p65. Arthritis Rheum., 38, 1762-1770.
36. Han Z., Boyle D. L., Chang L., Bennett B., Karin M., Yang L., Manning A. M. and Firestein G. S. (2001): c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest., 108, 73-81.
37. Han Z., Boyle D. L., Manning A. M. and Firestein G. S. (1998): AP-1 and NF-κB regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity, 28, 197-208.
38. Han Z., Boyle D. L., Shi Y., Green D. R. and Firestein G. S. (1999): Dominant-negative p53 mutations in rheumatoid arthritis. Arthritis Rheum., 42, 1088-1092.
39. Hanson G. J. (1998): DR (MHC class II) ligands: an approach to rheumatoid arthritis therapeutics. Curr. Pharm. Des., 4, 397-402.
40. Harvey J., Lotze M., Arnett F. C., Bias W. B., Billingsley L. M., Harvey E., Hsu S. H., Sutton J. D., Zizic T. M. and Stevens M. B. (1983): Rheumatoid arthritis in a Chippewa band. II. Field study with clinical serologic and HLA-D correlations. J. Rheumatol., 10, 28-32.
41. Hogaboam C. M., Steinhauser M. L., Chensue S. W. and Kunkel S. L. (1998): Novel roles for chemokines and fibroblasts in interstitial fibrosis. Kidney Int., 54, 2152-2159.
42. Horai R., Saijo S., Tanioka H., Nakae S., Sudo K., Okahara A., Ikuse T., Asano M. and Iwakura Y. (2000): Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J. Exp. Med., 191, 313-320.
43. Hu X., Herrero C., Li W. P., Antoniv T. T., Falck-Pedersen E., Koch A. E., Woods J. M., Haines G. K. and Ivashkiv L. B. (2002): Sensitization of IFN-γ Jak-STAT signaling during macrophage activation. Nat. Immunol., 3, 859-866.
44. Hwang S. Y., Kim J. Y., Kim K. W., Park M. K., Moon Y., Kim W. U. and Kim H. Y. (2004): IL-17 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via NF-κB-and PI3-kinase/Akt-dependent pathways. Arthritis Res. Ther., 6, R120-R128.
45. Jacobsson L. T. and Pillemer S. R. (1994): What can we learn about rheumatic diseases by studying Pima Indians? J. Rheumatol., 21, 1179-1182.
46. Jarvinen P. and Aho K. (1994): Twin studies in rheumatic diseases. Semin. Arthritis Rheum., 24, 19-28.
47. Kasperkovitz P. V., Verbeet N. L., Smeets T. J., van Rietschoten J. G., Kraan M. C., van der Pouw Kraan T. C., Tak P. P. and Verweij C. L. (2004): Activation of the STAT1 pathway in rheumatoid arthritis. Ann. Rheum. Dis., 63, 233-239.
48. Keffer J., Probert L., Cazlaris H., Georgopoulos S., Kaslaris E., Kioussis D. and Kollias G. (1991): Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J., 10, 4025-4031.
49. Kinne R. W., Brauer R., Stuhlmuller B., Palombo-Kinne E. and Burmester G. R. (2000): Macrophages in rheumatoid arthritis. Arthritis Res., 2, 189-202.
50. Kotlyarov A., Neininger A., Schubert C., Eckert R., Birchmeier C., Volk H. D. and Gaestel M. (1999): MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis. Nat. Cell Biol., 1, 94-97.
51. Kramer I., Wibulswas A., Croft D. and Genot E. (2003): Rheumatoid arthritis: targeting the proliferative fibroblasts. Prog. Cell Cycle Res., 5, 59-70.
52. Lalor P. A., Mapp P. I., Hall P. A. and Revell P. A. (1987): Proliferative activity of cells in the synovium as demonstrated by a monoclonal antibody, Ki67. Rheumatol. Int., 7, 183-186.
53. Lipsky P. E., van der Heijde D. M., St Clair E. W., Furst D. E., Breedveld F. C., Kalden J. R., Smolen J. S., Weisman M., Emery P., Feldmann M., Harriman G. R. and Maini R. N. (2000): Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. N. Engl. J. Med., 343, 1594-1602.
54. Lopez S., Halbwachs-Mecarelli L., Ravaud P., Bessou G., Dougados M. and Porteu F. (1995): Neutrophil expression of tumour necrosis factor receptors (TNF-R) and of activation markers (CD11b, CD43, CD63) in rheumatoid arthritis. Clin. Exp. Immunol., 101, 25-32.
55. Marinova-Mutafchieva L., Taylor P., Funa K., Maini R. N. and Zvaifler N. J. (2000): Mesenchymal cells expressing bone morphogenetic protein receptors are present in the rheumatoid arthritis joint. Arthritis Rheum., 43, 2046-2055.
56. Marinova-Mutafchieva L., Williams R. O., Funa K., Maini R. N. and Zvaifler N. J. (2002): Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum., 46, 507-513.
57. Mecklenburgh K. I., Walmsley S. R., Cowburn A. S., Wiesener M., Reed B. J., Upton P. D., Deighton J., Greening A. P. and Chilvers E. R. (2002): Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis. Blood, 100, 3008-3016.
58. Miyazawa K., Mori A., Yamamoto K. and Okudaira H. (1998): Constitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: spontaneous activation of NF-κB and CBF1. Am. J. Pathol., 152, 793-803.
59. Moulding D. A., Quayle J. A., Hart C. A. and Edwards S. W. (1998): Mcl-1 expression in human neutrophils: regulation by cytokines and correlation with cell survival. Blood, 92, 2495-2502.
60. Mulherin D., Fitzgerald O. and Bresnihan B. (1996): Synovial tissue macrophage populations and articular damage in rheumatoid arthritis. Arthritis Rheum., 39, 115-124.
61. Muller-Ladner U., Kriegsmann J., Franklin B. N., Matsumoto S., Geiler T., Gay R. E. and Gay S. (1996): Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am. J. Pathol., 149, 1607-1615.
62. + T cell accumulation in rheumatoid arthritis synovium. J. Immunol., 165, 6590-6598.
63. Nepom G. T., Byers P., Seyfried C., Healey L. A., Wilske K. R., Stage D. and Nepom B. S. (1989): HLA genes associated with rheumatoid arthritis. Identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum., 32, 15-21.
64. Newkirk M. M.(2002): Rheumatoid factors: what do they tell us? J. Rheumatol., 29, 2034-2040.
65. Ottonello L., Frumento G., Arduino N., Bertolotto M., Mancini M., Sottofattori E., Dallegri F. and Cutolo M. (2002): Delayed neutrophil apoptosis induced by synovial fluid in rheumatoid arthritis: role of cytokines, estrogens, and adenosine. Ann. NY Acad. Sci., 966, 226-231.
66. Perlman H., Pagliari L. J., Liu H., Koch A. E., Haines G. K. III and Pope R. M. (2001): Rheumatoid arthritis synovial macrophages express the Fas-associated death domain-like interleukin-1β-converting enzyme-inhibitory protein and are refractory to Fas-mediated apoptosis. Arthritis Rheum., 44, 21-30.
67. Pilling D., Akbar A. N., Girdlestone J., Orteu C. H., Borthwick N. J., Amft N., Scheel-Toellner D., Buckley C. D. and Salmon M. (1999): Interferon-β mediates stromal cell rescue of T cells from apoptosis. Eur. J. Immunol., 29, 1041-1050.
68. Pillinger M. H. and Abramson S. B. (1995): The neutrophil in rheumatoid arthritis. Rheum. Dis. Clin. North Am., 21, 691-714.
69. Qu Z., Garcia C. H., O'Rourke L. M., Planck S. R., Kohli M. and Rosenbaum J. T. (1994): Local proliferation of fibroblast-like synoviocytes contributes to synovial hyperplasia. Results of proliferating cell nuclear antigen/cyclin, c-myc, and nucleolar organizer region staining. Arthritis Rheum., 37, 212-220.
70. Robak T. and Gladalska A.(1997): Cytokines in rheumatoid arthritis. Postepy Hig. Med. Dosw., 51, 621-636.
71. Roshak A. K., Jackson J. R., McGough K., Chabot-Fletcher M., Mochan E. and Marshall L. A. (1996): Manipulation of distinct NFκB proteins alters interleukin-1β-induced human rheumatoid synovial fibroblast prostaglandin E2 formation. J. Biol. Chem., 271, 31496-31501.
72. Russell J. S., Brady K., Burgan W. E., Cerra M. A., Oswald K. A., Camphausen K. and Tofilon P. J. (2003): Gleevec-mediated inhibition of Rad51 expression and enhancement of tumor cell radiosensitivity. Cancer Res., 63, 7377-7383.
73. Salmon M., Scheel-Toellner D., Huissoon A. P., Pilling D., Shamsadeen N., Hyde H., D'Angeac A. D., Bacon P. A., Emery P. and Akbar A. N. (1997): Inhibition of T cell apoptosis in the rheumatoid synovium. J. Clin. Invest., 99, 439-446.
74. 74. Scheel-Toellner D., Wang K., Henriquez N. V., Webb P. R., Craddock R., Pilling D., Akbar A. N., Salmon M. and Lord J. M. (2002): Cytokine-mediated inhibition of apoptosis in non-transformed T cells and neutrophils can be dissociated from protein kinase B activation. Eur. J. Immunol., 32, 486-493.
75. Schett G., Tohidast-Akrad M., Smolen J. S., Schmid B. J., Steiner C. W., Bitzan P., Zenz P., Redlich K., Xu Q. and Steiner G. (2000): Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis. Arthritis Rheum., 43, 2501-2512.
76. Seki T., Selby J., Haupl T. and Winchester R. (1998): Use of differential subtraction method to identify genes that characterize the phenotype of cultured rheumatoid arthritis synoviocytes. Arthritis Rheum., 41, 1356-1364.
77. Seitz M., Loetscher P., Fey M. F. and Tobler A. (1994): Constitutive mRNA and protein production of macrophage colony-stimulating factor but not of other cytokines by synovial fibroblasts from rheumatoid arthritis and osteoarthritis patients. Br. J. Rheumatol., 33, 613-619.
78. Shiokawa Y. (1996): Fourty years' progress in rheumatology, and future perspectives in Japan. Ryumachi, 36, 662-669.
79. Silman A. J., MacGregor A. J., Thomson W., Holligan S., Carthy D., Farhan A. and Ollier W. E. (1993): Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br. J. Rheumatol., 32, 903-907.
80. Silverman G. J. and Carson D. A. (2003): Roles of B cells in rheumatoid arthritis. Arthritis Res. Ther., 5 (suppl. 4), S1-S6.
81. Sioud M., Mellbye O. and Forre O. (1998): Analysis of the NF-κB p65 subunit, Fas antigen, Fas ligand and Bcl-2-related proteins in the synovium of RA and polyarticular JRA. Clin. Exp. Rheumatol., 16, 125-134.
82. Smith R. S., Smith T. J., Blieden T. M. and Phipps R. P. (1997): Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am. J. Pathol., 151, 317-322.
83. Smolen J. S., Breedveld F. C., Eberl G., Jones I., Leeming M., Wylie G. L. and Kirkpatrick J. (1995): Validity and reliability of the twenty-eight-joint count for the assessment of rheumatoid arthritis activity. Arthritis Rheum., 38, 38-43.
84. Sun Y., Cheung J. M., Martel-Pelletier J., Pelletier J. P., Wenger L., Altman R. D., Howell D. S. and Cheung H. S. (2000): Wild type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMMP-13). J. Biol. Chem., 275, 11327-11332.
85. Sundarrajan M., Boyle D. L., Chabaud-Riou M., Hammaker D. and Firestein G. S. (2003): Expression of the MAPK kinases MKK-4 and MKK-7 in rheumatoid arthritis and their role as key regulators of JNK. Arthritis Rheum., 48, 2450-2460.
86. Tak P. P. and Firestein G. S. (2001): NF-κB: a key role in inflammatory diseases. J. Clin. Invest., 107, 7-11.
87. Tak P. P., Gerlag D. M., Aupperle K. R., van de Geest D. A., Overbeek M., Bennett B. L., Boyle D. L., Manning A. M. and Firestein G. S. (2001): Inhibitor of nuclear factor κB kinase β is a key regulator of synovial inflammation. Arthritis Rheum., 44, 1897-1907.
88. Tak P. P., Smeets T. J., Daha M. R., Kluin P. M., Meijers K. A., Brand R., Meinders A. E. and Breedveld F. C. (1997): Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum., 40, 217-225.
89. Tsao P. W., Suzuki T., Totsuka R., Murata T., Takagi T., Ohmachi Y., Fujimura H. and Takata I. (1997): The effect of dexamethasone on the expression of activated NF-κB in adjuvant arthritis. Clin. Immunol. Immunopathol., 83, 173-178.
90. Vaday G. G. and Lider O. (2000): Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J. Leukoc. Biol., 67, 149-159.
91. van der Pouw Kraan T. C., van Gaalen F. A., Kasperkovitz P. V., Verbeet N. L., Smeets T. J., Kraan M. C., Fero M., Tak P. P., Huizinga T. W., Pieterman E., Breedveld F. C., Alizadeh A. A. and Verweij C. L. (2003): Rheumatoid arthritis is a heterogeneous disease: evidence for differences in the activation of the STAT-1 pathway between rheumatoid tissues. Arthritis Rheum., 48, 2132-2145.
92. van Holten J., Plater-Zyberk C. and Tak P. P. (2002): Interferon-β for treatment of rheumatoid arthritis? Arthritis Res., 4, 346-352.
93. Verweij C. L. and Huizinga T. W. (1998): Tumour necrosis factor α gene polymorphisms and rheumatic diseases. Br. J. Rheumatol., 37, 923-926.
94. Wang K., Scheel-Toellner D., Wong S. H., Craddock R., Caamano J., Akbar A. N., Salmon M. and Lord J. M. (2003): Inhibition of neutrophil apoptosis by type 1 IFN depends on cross-talk between phosphoinositol 3-kinase, protein kinase C-δ, and NF-κB signaling pathways. J. Immunol., 171, 1035-1041.
95. Weinblatt M. E., Kremer J. M., Bankhurst A. D., Bulpitt K. J., Fleischmann R. M., Fox R. I., Jackson C. G., Lange M. and Burge D. J. (1999): A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N. Engl. J. Med., 340, 253-259.
96. Weiss S. J. (1989): Tissue destruction by neutrophils. N. Engl. J. Med., 320, 365-376.
97. Wibulswas A., Croft P., Bacarese-Hamilton I., McIntyre P., Genot E. and Kramer I. M. (2000): The CP44v7/8 epitope as a target to restrain proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Am. J. Pathol., 157, 2037-2044.
98. Yamanishi Y., Boyle P. L., Rosengren S., Green D. R., Zvaifler N. J. and Firestein G. S. (2002): Regional analysis of p53 mutations in rheumatoid arthritis synovium. Proc. Natl. Acad. Sci. USA, 99, 10025-10030.